Experience of DING Ying Treating Henoch Schonlein Purpura Nephritis from Theory of Blood-Stasis Blocking Collaterals by Using Rattan Medicines

DAI Yanlin; DING Ying; HAN Shanshan; XU Shanshan; HU Mingge; DU Mengke

doi:10.13192/j.issn.1000-1719.2022.06.007

Suggestions

您当前的位置：

首页 >

文章列表页 >

Experience of DING Ying Treating Henoch Schonlein Purpura Nephritis from Theory of Blood-Stasis Blocking Collaterals by Using Rattan Medicines

Previous: 无

Next: ZHANG Lishan's Experience on Treating Allergic Rhinitis with Qu feng Yizi Powder(驱风一字散)

Experience of DING Ying Treating Henoch Schonlein Purpura Nephritis from Theory of Blood-Stasis Blocking Collaterals by Using Rattan Medicines
1.Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan, China
2.The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan, China
DOI：10.13192/j.issn.1000-1719.2022.06.007

扫描看全文

DAI Yanlin, DING Ying, HAN Shanshan, et al. Experience of DING Ying Treating Henoch Schonlein Purpura Nephritis from Theory of Blood-Stasis Blocking Collaterals by Using Rattan Medicines[DB/OL].（2023-08-01）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2022.06.007
DOI：

DAI Yanlin, DING Ying, HAN Shanshan, et al. Experience of DING Ying Treating Henoch Schonlein Purpura Nephritis from Theory of Blood-Stasis Blocking Collaterals by Using Rattan Medicines[DB/OL].（2023-08-01）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2022.06.007 DOI：

摘要

紫癜性肾炎是儿童阶段最常见的一种继发性肾小球疾病，部分迁延不愈者可发展为终末期肾病，严重危害患儿生命健康。全国首批名中医丁樱教授从事儿科肾脏疾病40余年，围绕紫癜性肾炎的中医方案研究承担了“十一五、十二五”两个国家科技支撑计划课题，对紫癜性肾炎的治疗积累了丰富的经验，认为本病病机关键为络脉瘀阻，故治疗上以舒经通络、活血化瘀为基本原则，而藤类药具有缠绕蔓延、纵横交错之形，似人之络脉遍布全身，能够浅入阳络，深入阴络，驱逐络脉滞留之邪，为通络之佳品，活血之良药，临床应用数载，疗效显著。文章对丁樱教授临床运用藤类药从络脉瘀阻论治紫癜性肾炎经验进行总结，进一步探究了藤类药的用药及用量选择，以期更好地服务于临床。

Abstract

Henoch Schonlein purpura nephritis is one of the most common secondary glomerular diseases in children. Some patients who do not recover can develop into end-stage renal disease, which seriously endangers the life and health of children. Professor DING Ying, one of the first famous TCM doctors in China, has been engaged in pediatric nephropathy for more than 40 years, and has undertaken two national science and technology support plan projects around the research of purpura nephritis, and has accumulated rich experience in the treatment of Henoch Schonlein purpura nephritis. She thinks that the key to the pathogenesis of the disease is blood-stasis blocking collaterals, so the basic principle of treatment is to relax the meridians and unblock collaterals, and promote blood circulation to remove blood stasis. Rattan medicines have the shape of winding and spreading, crisscrossing, like human collaterals all over the body. It is a good product to open the ligaments and invigorate blood, and has been clinically applied for several years with remarkable efficacy. This article summarizes Professor DING Ying's experience on treating purpura nephritis from the perspective of blood-stasis blocking collaterals, and further explores the choice of rattan medicines and dosages in order to better serve the clinic.

关键词

丁樱紫癜性肾炎络脉瘀阻藤类药

Keywords

DING YingHenoch Schonlein purpura nephritisblood-stasis blocking collateralsrattan medicines

references

FU H, MAO J, XU Y, et al. Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schonlein purpura nephritis in children [J]. Clinics(Sao Paulo), 2016, 71(9): 550-554.

DELBET J D, GESLAIN G, AUGER M, et al. Histological prognostic factors in children with Henoch-Schonlein purpura nephritis [J]. Pediatr Nephrol, 2020, 35(2): 313-320.

SHI D, CHAN H, YANG X, et al. Risk factors associated with IgA vasculitis with nephritis(Henoch-Schonlein purpura nephritis)progressing to unfavorable outcomes: A meta-analysis [J]. PLoS ONE, 2019, 14(10): e0223218.

中华医学会儿科学分会肾脏学组.紫癜性肾炎诊治循证指南(2016)[J].中华儿科杂志, 2017, 55(9): 647-651.

丁樱, 翟文生, 任献青, 等.雷公藤多苷联合清热止血方、香丹注射液治疗小儿紫癜性肾炎疗效观察[J].中国中西医结合杂志, 2012, 32(9): 1290-1292.

王龙, 徐闪闪, 代彦林, 等.雷公藤多苷片联合清热止血方对紫癜性肾炎患者的临床疗效[J].中成药, 2021, 43(4): 914-918.

代彦林, 吕晓颖, 高敏, 等.基于数据挖掘分析丁樱教授治疗紫癜性肾炎的用药规律及思想[J].辽宁中医杂志, 2021, 48(2): 9-13.

吴以岭.络病学[M].北京: 中国科学技术出版社, 2005: 60-68.

任献青, 郑贵珍, 管志伟, 等.丁樱教授从热、瘀、虚辨治小儿过敏性紫癜性肾炎经验[J].中华中医药杂志, 2013, 28(12): 3586-3588.

闫永彬, 丁樱, 任献青, 等.丁樱学术思想及临证精华述要[J].中华中医药杂志, 2016, 31(1): 132-134.

中华医学会儿科学分会免疫学组, 《中华儿科杂志》编辑委员会.儿童过敏性紫癜循证诊治建议[J].中华儿科杂志, 2013, 51(7): 502-507.

刘玉宁, 王耀献.藤类药治疗肾小球疾病临床运用体会[J].上海中医杂志, 2012, 46(9): 70-71.

崔雅璠, 丁樱.配伍应用海风藤、络石藤、忍冬藤治疗顽固性过敏性紫癜经验[J].辽宁中医杂志, 2014, 41(10): 2062-2063.

田莹莹, 邵晓珊, 李宇红, 等.牛津病理分型在儿童紫癜性肾炎评估中的价值[J].临床儿科杂志, 2021, 39(2): 81-86.

王贞佐, 呼海涛, 孟庆繁, 等.海风藤的研究进展[J].时珍国医国药, 2006, 17(7): 1305-1307.

赵媛媛, 杨倩茹, 郝江波, 等.金银花与忍冬藤及叶药理作用差异的研究进展[J].中国中药杂志, 2016, 41(13): 2422-2427.

鲁思爱.忍冬藤的化学成分及其药理应用研究进展[J].临沂大学学报, 2012, 34(3): 132-134.

李建国, 谢兴文, 李宁, 等.忍冬藤痛风颗粒治疗湿热蕴结型痛风性关节炎的临床研究[J].时珍国医国药, 2019, 30(10): 2416-2418.

王贞佐, 呼海涛, 孟庆繁, 等.海风藤的研究进展[J].时珍国医国药, 2006, 17(7): 1305-1307.

高学敏.中药学[M].北京: 中国中医药出版社, 2007: 90-91.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰